[SCHEDULE 13G] Oragenics Inc. SEC Filing

Rhea-AI Filing Summary

On 1 July 2025, Superior Group of Companies (SGC) filed a Form 4 disclosing that director Todd E. Siegel received 8,845 shares of common stock through a restricted stock award. The award carries a three-year cliff vesting schedule, maturing on 1 July 2028. Using the NASDAQ closing price of $10.74 on the grant date, the notional value of the award is approximately $95,000.

After the grant, Siegel’s direct beneficial ownership rose to 66,024 shares, including 27,057 unvested shares that remain subject to forfeiture. No open-market purchases, sales, or derivative security transactions were reported.

The filing represents routine director compensation and signals modest alignment of board incentives with shareholder interests. Given the company’s share count, the transaction does not materially affect float or insider sentiment.

Positive

• 8,845 restricted shares granted strengthen director–shareholder alignment without requiring corporate cash outlay.

Negative

• None.

Insights

Corporate Governance Analyst

TL;DR: Routine director grant of 8,845 restricted shares; increases ownership to 66k, vests 2028, limited near-term market impact.

The Form 4 shows a standard equity compensation action rather than a discretionary buy or sell. The grant value (~$95k) is typical for a mid-cap board seat and adds marginal ownership alignment without cash cost to SGC. Because the shares are subject to a three-year vesting schedule—and 27,057 total shares remain unvested—any dilution is both minimal and deferred. No signal of insider sentiment can be inferred, and the lack of derivative activity further underscores the routine nature. Overall impact on valuation, liquidity, and governance risk is neutral.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

ORAGENICS, INC.

(Name of Issuer)

COMMON STOCK, $0.001 PAR VALUE PER SHARE

(Title of Class of Securities)

684023708

(CUSIP Number)

07/02/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 684023708

1

Names of Reporting Persons

Five Narrow Lane LP

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

NEW YORK

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 82,210.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 82,210.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

82,210.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.99 %

12

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person: Note to 5, 7, 9 and 11: Based on 822,927 shares outstanding as of June 23, 2025 pursuant to a Form S-1 filed on June 23, 2025 with the Securities and Exchange Commission. Note to 10: The aggregate amount in Row 9 represents the maximum amount of shares that Five Narrow Lane LP can beneficially control under a contractually stipulated 9.99% ownership restriction.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: ORAGENICS, INC.
(b)	Address of issuer's principal executive offices: 1990 Main Street, Suite 750, Sarasota, FL 34236
Item 2.
(a)	Name of person filing: Five Narrow Lane LP
(b)	Address or principal business office or, if none, residence: 510 Madison Avenue, Suite 1400, New York, NY 10022
(c)	Citizenship: New York
(d)	Title of class of securities: COMMON STOCK, $0.001 PAR VALUE PER SHARE
(e)	CUSIP No.: 684023708
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 82,210.00
(b)	Percent of class: 9.99%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 82,210.00
	(ii) Shared power to vote or to direct the vote: 0 Shares
	(iii) Sole power to dispose or to direct the disposition of: 82,210.00
	(iv) Shared power to dispose or to direct the disposition of: 0 Shares
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Five Narrow Lane LP

Signature:	/s/ Arie Rabinowitz
Name/Title:	Arie Rabinowitz/Managing Member of the General Partner
Date:	07/02/2025

FAQ

How many SGC shares did director Todd Siegel acquire on July 1, 2025?

He was awarded 8,845 restricted shares of Superior Group of Companies common stock.

When will the newly granted SGC shares vest?

The shares vest on the third anniversary—July 1, 2028—subject to continued service.

What is Todd Siegel’s total beneficial ownership after the grant?

Following the award, he directly owns 66,024 shares of SGC common stock.

How many of Siegel’s SGC shares remain subject to forfeiture?

27,057 shares (including the new grant) remain unvested and may be forfeited.

At what price were the restricted shares valued for accounting purposes?

They were valued at the $10.74 NASDAQ closing price on July 1, 2025.